Recovery Watch headlines:

• Pfizer/BioNTech vaccine appears highly effective against South African variant
• Oxford/AstraZeneca rollout halted for some in Europe, as regulators conclude that unusual blood clots should be listed as a ‘possible but very rare’ side effect
• Policymakers make very cautious assumptions about the pace of recovery…

[Please click below to read the full note.]